Literature DB >> 24140063

C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells.

Pin Guo1, Quanmin Nie, Jin Lan, Jianwei Ge, Yongming Qiu, Qing Mao.   

Abstract

The c-Myc oncogene is amplified in many tumor types. It is an important regulator of cell proliferation and has been linked to altered miRNA expression, suggesting that c-Myc-regulated miRNAs might contribute to tumor progression. Although miR-26a has been reported to be upregulated in glioblastoma multiforme (GBM), the mechanism has not been established. We have shown that ectopic expression of miR-26a influenced cell proliferation by targeting PTEN, a tumor suppressor gene that is inactivated in many common malignancies, including GBM. Our findings suggest that c-Myc modulates genes associated with oncogenesis in GBM through deregulation of miRNAs via the c-Myc-miR-26a-PTEN signaling pathway. This may be of clinical relevance.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3′-UTR; 3′-untranslated region; AML; B-cell lymphoma; BCL; C-Myc; CCK-8; Cell Counting Kit-8; GBM; Glioblastoma multiforme; MiR-26a; PTEN; Proliferation; acute myeloid leukemia; glioblastoma multiforme; miRNA; microRNA; phosphatase and tensin homolog located on chromosome 10

Mesh:

Substances:

Year:  2013        PMID: 24140063     DOI: 10.1016/j.bbrc.2013.10.034

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Studies on microRNAs that are correlated with the cancer stem cells in chronic myeloid leukemia.

Authors:  Xishan Zhu; Ziying Lin; Jing Du; Xu Zhou; Lawei Yang; Gang Liu
Journal:  Mol Cell Biochem       Date:  2014-01-03       Impact factor: 3.396

Review 2.  The role of microRNA-26a in human cancer progression and clinical application.

Authors:  Jing Chen; Kai Zhang; Yuejuan Xu; Yanping Gao; Chen Li; Rui Wang; Longbang Chen
Journal:  Tumour Biol       Date:  2016-04-02

3.  MicroRNA-26a prevents endothelial cell apoptosis by directly targeting TRPC6 in the setting of atherosclerosis.

Authors:  Yong Zhang; Wei Qin; Longyin Zhang; Xianxian Wu; Ning Du; Yingying Hu; Xiaoguang Li; Nannan Shen; Dan Xiao; Haiying Zhang; Zhange Li; Yue Zhang; Huan Yang; Feng Gao; Zhimin Du; Chaoqian Xu; Baofeng Yang
Journal:  Sci Rep       Date:  2015-03-24       Impact factor: 4.379

Review 4.  Glioblastoma: molecular pathways, stem cells and therapeutic targets.

Authors:  Meena Jhanwar-Uniyal; Michael Labagnara; Marissa Friedman; Amanda Kwasnicki; Raj Murali
Journal:  Cancers (Basel)       Date:  2015-03-25       Impact factor: 6.639

5.  Failure of the PTEN/aPKC/Lgl Axis Primes Formation of Adult Brain Tumours in Drosophila.

Authors:  Simona Paglia; Manuela Sollazzo; Simone Di Giacomo; Dario de Biase; Annalisa Pession; Daniela Grifoni
Journal:  Biomed Res Int       Date:  2017-12-27       Impact factor: 3.411

Review 6.  MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma.

Authors:  Huda Alfardus; Alan McIntyre; Stuart Smith
Journal:  Biomed Res Int       Date:  2017-07-19       Impact factor: 3.411

7.  The regulatory role of aberrant Phosphatase and Tensin Homologue and Liver Kinase B1 on AKT/mTOR/c-Myc axis in pancreatic neuroendocrine tumors.

Authors:  Tsung-Ming Chang; Yan-Shen Shan; Pei-Yi Chu; Shih Sheng Jiang; Wen-Chun Hung; Yu-Lin Chen; Hsiu-Chi Tu; Hui-You Lin; Hui-Jen Tsai; Li-Tzong Chen
Journal:  Oncotarget       Date:  2017-09-16

Review 8.  MicroRNAs in congenital heart disease.

Authors:  Tanya Smith; Cha Rajakaruna; Massimo Caputo; Costanza Emanueli
Journal:  Ann Transl Med       Date:  2015-12

Review 9.  MicroRNAs: novel players in cancer diagnosis and therapies.

Authors:  Aaron L Oom; Brock A Humphries; Chengfeng Yang
Journal:  Biomed Res Int       Date:  2014-07-02       Impact factor: 3.411

10.  Smurf2 E3 ubiquitin ligase modulates proliferation and invasiveness of breast cancer cells in a CNKSR2 dependent manner.

Authors:  Diana David; Sankar Jagadeeshan; Ramkumar Hariharan; Asha Sivakumari Nair; Radhakrishna Madhavan Pillai
Journal:  Cell Div       Date:  2014-08-31       Impact factor: 5.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.